Hong Kong stock market anomaly | Sis Pharmaceutical Group (02005.HK) rose more than 7% recently with its subsidiary reaching a cooperation agreement with Opterion to introduce the innovative kidney disease drug OPT101.

According to the Interactive Financial News app, Shis Pharmaceutical Group (02005.HK) rose by more than 7%, closing at a 6.93% increase, at 2.16 Hong Kong dollars, with a trading volume of 16.02 million Hong Kong dollars as of the time of publication.